Predict your next investment

HEALTHCARE | Drug Delivery
sphenocath.com

See what CB Insights has to offer

Stage

Unattributed | Alive

Total Raised

$800K

Last Raised

$800K | 8 yrs ago

About Dolor Technologies

Dolor Technologies is dedicated to the development of pain management and drug delivery devices. In the U.S., Dolor Technologies currently offers SphenoCath through regional distributors. SphenoCath is a single-use, disposable catheter that delivers medication through the nasal passages to a difficult-to-reach ganglion located at the back of the nose without needles, sprays, swabs or sedation.

Dolor Technologies Headquarter Location

10967 Topview Road

South Jordan, Utah, 84095,

United States

360-907-6831

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Dolor Technologies Patents

Dolor Technologies has filed 5 patents.

The 3 most popular patent topics include:

  • Anesthesia
  • General anesthetics
  • Local anesthetics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/10/2012

1/1/2019

Neurological disorders, Syndromes, Rare diseases, Analgesics, Chronic pain syndromes

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

2/10/2012

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

1/1/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Neurological disorders, Syndromes, Rare diseases, Analgesics, Chronic pain syndromes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.